Announce Date | 05/05/2025 |
EPS Normalized Actual | $1.45 (Miss by $-0.12) |
EPS GAAP Actual | $1.45 (Miss by $-0.12) |
Revenue Actual | $1.668B |
Revenue Surprise | Beat by $1668M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2029 | 0 | INF | 0 | 0 | 3 |
Jun 2028 | 7.8951 | 17.07 | 7.70787 | 8.09806 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.51 | 1.51 | 1.668B | -8.75% | 1668M |
FQ4 2024 (Dec 2024) | 1.56 | 1.56 | 1.686B | -18.03% | 1686M |
FQ3 2024 (Sep 2024) | 0.8 | 0.8 | 1.762B | 21.34% | 1762M |
FQ2 2024 (Jun 2024) | 1.74 | 1.74 | 1.903B | -6.1% | 1903M |
FQ1 2024 (Mar 2024) | -0.0004 | -0.0004 | 1.814B | -5.57% | 1814M |
FQ4 2023 (Dec 2023) | 0.75 | 0.75 | 1.99B | 99.85% | 1990M |
FQ3 2023 (Sep 2023) | 0.18 | 0.18 | 1.386B | 99.86% | 1386M |
FQ2 2023 (Jun 2023) | 1.43 | 1.43 | 2.019B | 100% | 2019M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 5 |
FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 4 |
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 7 |
FQ1 2027 (Mar 2027) | 1.90119 | -- | 1.85969 | 1.92928 | 4 |
FQ4 2026 (Dec 2026) | 1.78188 | -- | 1.74298 | 1.80821 | 9 |
FQ3 2026 (Jul 2026) | 1.9197 | -- | 1.83827 | 2.01661 | 5 |
FQ1 2026 (Mar 2026) | 1.74054 | 13.25 | 1.67608 | 1.83656 | 4 |
FQ4 2025 (Oct 2025) | 1.5861 | 1.65 | 1.51882 | 1.66617 | 4 |
FQ3 2025 (Sep 2025) | 1.60604 | 50.19 | 1.54656 | 1.69464 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 2.02B | -- | 1.97B | 2.1B | 7 |
FQ4 2027 (Dec 2027) | 1.86B | -- | 1.82B | 1.94B | 7 |
FQ3 2027 (Sep 2027) | 1.94B | -- | 1.89B | 2.02B | 4 |
FQ1 2027 (Mar 2027) | 1.93B | -- | 1.89B | 1.95B | 4 |
FQ4 2026 (Dec 2026) | 1.78B | -- | 1.75B | 1.81B | 5 |
FQ3 2026 (Jul 2026) | 2.09B | -- | 2.02B | 2.17B | 5 |
FQ1 2026 (Mar 2026) | 2.03B | 17.81 | 1.97B | 2.12B | 7 |
FQ4 2025 (Oct 2025) | 1.78B | 5.06 | 1.72B | 1.84B | 2 |
FQ3 2025 (Sep 2025) | 1.82B | 3.25 | 1.77B | 1.9B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.51 | 1.51 | 100% | |
FQ4 2024 (Dec 2024) | 1.56 | 1.56 | 100% | |
FQ3 2024 (Sep 2024) | 0.8 | 0.8 | 100% | |
FQ2 2024 (Jun 2024) | 1.74 | 1.74 | 100% | |
FQ1 2024 (Mar 2024) | -0.0004 | -0.0004 | 100% | |
FQ4 2023 (Dec 2023) | 0.75 | 0.75 | 100% | |
FQ3 2023 (Sep 2023) | 0.18 | 0.18 | 100% | |
FQ2 2023 (Jun 2023) | 1.43 | 1.43 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.67B | $1668M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.69B | $1686M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.76B | $1762M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.9B | $1903M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.81B | $1814M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.99B | $1990M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.39B | $1386M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.02B | $2019M | 100% |